Sensex drops 622 pts; FMCG shares slide

Sensex drops 622 pts; FMCG shares slide


The key equity indices traded with substantial losses in the mid-morning trade, pressured by escalating tensions in the Iran-Israel-US conflict, persistent selling by foreign institutional investors (FIIs), and a surge in crude oil prices above the $100-per-barrel mark. The heightened geopolitical uncertainty dampened investor sentiment, dragging the Nifty below the 23,700 level. FMCG stocks remained under pressure, extending their decline for the second consecutive session.

At 11:30 IST, the barometer index, the S&P BSE Sensex, dropped 621.98 points or 0.82% to 76,241.91. The Nifty 50 index fell 182.60 points or 0.75% to 23,680.20.

The broader market underperformed the frontline indices. The BSE 150 MidCap Index declined 0.67% and the BSE 250 SmallCap Index fell 0.62%.

 

The market breadth was weak. On the BSE, 1,419 shares rose and 2,457 shares fell. A total of 226 shares were unchanged.

The NSE’s India VIX, a gauge of the market’s expectation of volatility over the near term, rallied 3.38% to 21.78.

IPO Update:

The initial public offer (IPO) of Innovision received bids for 12,56,310 shares as against 61,32,433 shares on offer, according to stock exchange data at 11:30 IST on Thursday (12 March 2026). The issue was subscribed 0.20 times.

The issue opened for bidding on 10 March 2026 and it will close on 12 March 2026. The price band of the IPO is fixed between Rs 521 and 548 per share.

Buzzing Index:

The Nifty FMCG index fell 1.44% to 48,354.90. The index dropped 2.51% in two consecutive trading sessions.

Varun Beverages (down 3.46%), Godrej Consumer Products (down 3.25%), Radico Khaitan (down 2.40%), Colgate-Palmolive (India) (down 2.02%), Dabur India (down 1.92%), Britannia Industries (down 1.75%), United Spirits (down 1.53%), Hindustan Unilever (down 1.29%), Patanjali Foods (down 1.25%) and Tata Consumer Products (down 1.03%) declined.

Stocks in Spotlight:

VA TECH WABAG rose 0.83%. The company said that it has secured a ‘mega public-private partnership (PPP) contract from the Chennai Metropolitan Water Supply and Sewerage Board (CMWSSB), for a 45 MLD TTRO Plant in Chennai.

ACME Solar Holdings (ACME Solar) rallied 3.93% after the company informed through its subsidiary ACME Greentech Seventh, has signed two power purchase agreements (PPAs) with SJVN for a total capacity of 450 MW/1,800 MWh.

Global Markets:

Most Asian markets fell on Thursday as investors grappled with volatile oil prices and escalating tensions in the Middle East, even after the U.S. and its allies announced an unprecedented emergency release of crude reserves to calm energy markets.

The International Energy Agency is looking to release 400 million barrels of oil following the supply disruption owed to the Iran war, the largest such action in the organizations history. The IEA did not set out a timeline for when the stocks would hit the market.

The U.S. will release 172 million barrels of oil from the Strategic Petroleum Reserve to help lower energy costs, Energy Secretary Chris Wright reportedly said Wednesday evening stateside.

The announcement from the Energy Secretary came after President Donald Trump said earlier in the day that he would tap the Strategic Petroleum Reserve to keep a lid on energy prices.

Overnight in the U.S., the Dow Jones Industrial Average fell as investors continued to eye developments in the U.S.-Iran war and oil prices.

The 30-stock index shed 289.24 points, or 0.61%, to close at 47,417.27. The S&P 500 inched down 0.08% to settle at 6,775.80, while the Nasdaq Composite ticked up 0.08% to end the session at 22,716.13.

Powered by Capital Market – Live News



Source link

Sensex drops 622 pts; FMCG shares slide

Nifty slides below 23,650 mark; auto shares drop


The headline equity indices witnessed sharp losses in morning trade, pressured by escalating tensions in the Iran-Israel-US conflict, persistent selling by foreign institutional investors (FIIs), and a surge in crude oil prices above the $100-per-barrel mark. The heightened geopolitical uncertainty dampened investor sentiment, dragging the Nifty below the 23,650 level. Auto stocks remained under pressure, extending their decline for the second consecutive session amid the broader market weakness.

At 10:30 IST, the barometer index, the S&P BSE Sensex, dropped 691.92 points or 0.90% to 76,171.79. The Nifty 50 index fell 232.15 points or 0.98% to 23,636.50.

The broader market underperformed the frontline indices. The BSE 150 MidCap Index tumbled 1.28% and the BSE 250 SmallCap Index slumped 1.35%.

 

The market breadth was weak. On the BSE, 1,075 shares rose and 2,596 shares fell. A total of 216 shares were unchanged.

The NSE’s India VIX, a gauge of the market’s expectation of volatility over the near term, rallied 5.18% to 22.16.

Buzzing Index:

The Nifty Auto index tumbled 2.93% to 25,166.95. The index dropped 5.99% in two consecutive trading sessions.

TVS Motor Company (down 3.71%), Bharat Forge (down 3.65%), Mahindra & Mahindra (down 3.59%), Samvardhana Motherson International (down 2.96%), Tata Motors Passenger Vehicles (down 2.95%), Hero MotoCorp (down 2.7%), Ashok Leyland (down 2.47%), Bosch (down 2.43%), Maruti Suzuki India (down 2.41%) and Tube Investments of India (down 2.38%) declined.

Stocks in Spotlight:

Enviro Infra Engineers jumped 8.51% after the company has secured a new project from Bihar Urban Infrastructure Development Corporation for the development of sewerage network and Sewage treatment plant (STP) at Aurangabad.

Relaxo Footwears slipped 1.51% after Prince Jain resigned as chief financial officer (CFO) and key managerial personnel (KMP) of the company, effective from the close of business hours on 11 March 2026.

Powered by Capital Market – Live News



Source link

Markets crash yet again: Why are Sensex, Nifty falling today? Key reasons

Markets crash yet again: Why are Sensex, Nifty falling today? Key reasons



Stock market crash today reasons: Stock market benchmark indices Sensex and Nifty opened deep in the red today as investor sentiment remained fragile amid escalating geopolitical tensions in the Middle East. The BSE Sensex started the session with a cut of nearly 500 points at 76,369.65. The index made a low of 75,871.18, down 992 points or 1.3 per cent in early morning deals. Similarly, the Nifty 50 index fell 192 points or 0.80 per cent to open at 23,674. The 50-share pack made a low of 23,556.30 as it cracked 310 points or 1.30 per cent.


As of 9:35AM, both the benchmark indices were trading near their lows with Sensex quoting at 75,965 and Nifty at 23,585.

 


The sectoral participation remained negative, reflecting broad-based weakness across the market. All the indices were trading in the red, with the Nifty Auto, Nifty Realty, and Nifty Consumer Durables falling more than 2 per cent each. The Nifty Bank index tumbled 750 points or 1.3 per cent to trade at 54,980, with all 14 constituents trading in the red.


On the broader front, pressure was visible across the board. The Nifty Midcap 100 and Nifty Smallcap 100 indices declined more than 1.5 per cent.


India VIX, the fear gauge index, spiked 4 per cent to cross the 21 mark, signaling underlying uncertainty in the markets.


With today’s sharp decline, the BSE Sensex has lost more than 2,300 points, while the NSE Nifty has dipped over 700 points. In the previous session, the 30-share BSE Sensex tumbled 1,342.27 points or 1.72 per cent to 76,863.71. The NSE Nifty tanked 394.75 points or 1.63 per cent to 23,866.85.


Markets crash today: Key reasons


Oil prices above $100: Brent crude jumped above $100 a barrel after Oman cleared all vessels from its key export oil terminal and two tankers were attacked in Iraqi waters, underscoring the broader risks to energy assets across the Middle East and overshadowing a record release from the IEA. The global benchmark soared as much as 10.5 per cent to $101.59 a barrel, while West Texas Intermediate surged near $96.


VK Vijayakumar, Chief Investment Strategist, Geojit Investments, said that external headwinds have pushed the market into a weak zone. With the war continuing to rage with no signs of let up and Brent crude again bouncing back to $100 levels, the weakness is likely to persist.


Weak INR: The rupee depreciated 31 paise to 92.32 against the US dollar today, pressured by FII outflows, rising global crude oil prices and a stronger greenback. The local unit declined 16 paise to settle at 92.01 against the US dollar on Wednesday.


Dilip Parmar, senior research analyst, HDFC Securities, said that intensified geopolitical tensions in West Asia have triggered risk-averse sentiment and pushed crude oil prices higher — both of which have weighed heavily on the rupee. Tight dollar liquidity has further exacerbated the decline, driven by capital outflows from domestic equity and debt markets.


In the near term, the analyst said, spot USDINR finds immediate support at 91.60, with key resistance seen at 92.40.


The dollar index, which gauges the greenback’s strength against a basket of six currencies, was trading 0.24 per cent higher at 99.47.


Global markets: Shares fell in Asia as oil prices jumped on reports that more ships had been struck in the Strait of Hormuz and in Iraqi waters. Japan’s Nikkei 225 index fell 1.8 per cent, and South Korea’s Kospi and Hong Kong’s Hang Seng index also dropped 1.2 per cent each. Shanghai’s SSE Composite index was seen trading in the red with a loss of 0.65 per cent.


Overnight, the US markets ended mostly flat, with the Dow Jones and the S&P 500 down slightly. The tech heavyweight Nasdaq Composite settled with positive bias. 



Source link

Jefferies names Sai Life Sciences top CRDMO pick, lists 10 reasons to buy

Jefferies names Sai Life Sciences top CRDMO pick, lists 10 reasons to buy



Sai Life Sciences Ltd. is Jefferies’ top pick in the contract research, development, and manufacturing organisation (CRDMO) space, citing its integrated business model, strong growth outlook, and healthy pipeline as key drivers.

 


The brokerage maintained a ‘Buy’ rating on the stock with a revised price target of ₹1,300 (29 per cent upside) and raised its estimates, increasing its Financial Year 2028 (FY28) sales estimate by 3 per cent and earnings per share estimate by 5 per cent.

 


Jefferies said Sai Life Sciences follows a proven ‘follow-the-molecule’ model, engaging with clients from the discovery stage and supporting them through commercialisation and lifecycle management. The company has a balanced mix between contract research organisation (CRO) and contract development and manufacturing organisation (CDMO) services at about 35:65, allowing early entry into projects while sustaining growth, it added. 

 
 


The brokerage noted that Sai Life remains relatively small compared with its addressable market, with FY25 sales of about $200 million, providing significant room for expansion. Over FY23 to FY26 estimates, the company has delivered a sales compound annual growth rate (CAGR) of 23 per cent and Ebitda CAGR of 57 per cent. Jefferies expects sales and Ebitda to grow at a CAGR of 17 per cent and 20 per cent, respectively, between FY26 and FY28.

 


The company has also continued to add new projects due to healthy win rates. In FY26, it added seven new molecules, including three commercial molecules and four in Phase III trials. Among the commercial molecules, Sai Life Sciences is believed to be the primary supplier for two, which could become meaningful revenue contributors in the coming years. Jefferies estimates that key pipeline projects could address end-market sales of more than $13 billion by calendar year 2028.

 


Jefferies added that there is no private equity overhang on the stock after TPG, which held about 39 per cent stake before the initial public offering, fully exited in 2025. The company also benefits from an international presence with around 110 scientists across pharmaceutical hubs such as Boston and Manchester, helping it develop new client relationships.

 


Sai Life Sciences currently has a net debt-neutral balance sheet, and Jefferies expects leverage to remain below 0.5 times or the company to remain in a net cash position over the next several years despite ongoing capital expenditure. 

 


Despite delivering about 45 per cent returns since its initial public offering, including listing gains of around 20 per cent, the stock trades at about 47 times FY27 estimated earnings, broadly in line with the sector average of 48-50 times.

 


Jefferies also sees scope for further earnings upgrades, noting that since initiating coverage on the stock in March 2025 it has raised its FY26 revenue and profit estimates by 17 per cent and 30 per cent, respectively, and FY27 estimates by 19 per cent and 25 per cent. The brokerage said the upgrade cycle could continue as the company converts new sample supplies and an animal health project into larger commercial opportunities.

 


==========

 


(Disclaimer: The views and investment tips expressed by the analysts in this article are their own and not those of the website or its management. Business Standard advises users to check with certified experts before taking any investment decisions.)

 



Source link

Stocks to buy: ABB India, Venus Remedies, Karnataka Bk are on analyst radar

Stocks to buy: ABB India, Venus Remedies, Karnataka Bk are on analyst radar


Stock Recommendations by Kunal Kamble


Stock recommendations by Kunal Kamble, Bonanza


ABB India

ABB India Limited has shown a strong recovery from the major demand zone near 4,800–5,000, where the stock formed a solid base supported by increased volumes. The price has now moved above key short- and medium-term moving averages, indicating improving momentum and a potential trend reversal. The recent breakout above the 6,200 resistance zone signals renewed buying interest and strengthening bullish sentiment. Additionally, the formation of higher highs and higher lows suggests continuation of the upward trend. 

 


Buy range: ₹6,280 


Stop-loss: ₹5,800 


Target: ₹7,150 


Venus Remedies

Venus Remedies Limited has given a strong breakout above the key resistance zone near 830 on the daily chart, supported by a sharp bullish candle and noticeable rise in volumes, indicating strong buying interest. The stock is trading above its short- and medium-term moving averages, reflecting positive momentum and strengthening trend structure. Additionally, RSI has moved towards 69, suggesting improving bullish momentum without being extremely overbought. 

 
 


Buy range: ₹862 


Stop-loss: ₹786 


Target: 1,050


Karnataka Bank

Karnataka Bank Limited has recently shown a strong breakout from a long-term descending trendline on the daily chart, indicating a potential trend reversal. The stock witnessed increased buying interest supported by a surge in volumes, suggesting accumulation at lower levels. Prices have moved above the short- and medium-term moving averages, reflecting improving momentum. Additionally, the RSI is trending near 68, indicating strengthening bullish momentum. 

 


Buy range: ₹229 


Stop-loss: ₹206 


Target: ₹275  (Disclaimer: This article is by Kunal Kamble, senior technical research analyst, Bonanza Portfolio. Views expressed are his own.)

First Published: Mar 12 2026 | 6:45 AM IST



Source link

YouTube
Instagram
WhatsApp